Our group also reported DNMT3A and DNMT3B overexpression in RMS tumour primary biopsies and cell lines compared to normal skeletal muscle, so revealing the oncogenic role of DNMT3B in ERMS cell lines [25]. The gene discussed is DNMT3B; the disease is neoplasm.